Digital health funding in H1 2025: what to know

Digital health funding held steady in the first half of 2025, with AI-focused startups capturing the majority of capital and driving rapid adoption among providers. The digital health space also saw two long-awaited IPOs as well as rising M&A activity, which are two signals of market maturity — but looming policy shifts may challenge long-term growth.

Editor's Pick

Top Story Digital Health Funding in H1 2025: Market Stabilizes, AI Dominates and Exits Return Digital health funding held steady in the first half of 2025, with AI-focused startups capturing the majority of capital and driving rapid adoption among providers. The digital health space also saw two long-awaited IPOs as well as rising M&A activity, which are two signals of market maturity — but looming policy shifts may challenge long-term growth. Sponsored The Best Group Nutrition Programs for Weight Loss: A Comprehensive Guide Presented by Doherty Nutrition Everyone has a different idea or method for losing weight. These leaders in nutrition offer guidance on finding the right fit. Learn More. 🧠 The Future of Digital Health Is Here MedCity INVEST Digital Health is back—September 18, 2025, at Pegasus Park in Dallas. This one-day, high-impact event brings together the brightest minds in healthcare innovation—healthcare leaders, investors, and the most promising startups—to discuss the trends shaping the future of care. Why Attend? ✅ Top-tier networking with decision-makers and deal-makers ✅ Expert panels on AI, digital therapeutics, and value-based care ✅ Pitch competition spotlighting the hottest digital health startups ✅ Curated connections between investors and innovators 🎟️ Space is limited. Reserve your spot now

Featured News

KalVista Drug Gets FDA Approval for Treating Acute Swelling Attacks From Rare Disease KalVista Pharmaceuticals' Ekterly is now FDA approved for treating acute swelling attacks from hereditary angioedema. The KalVista tablet provides an alternative to injectable or infused HAE medications from companies such as Takeda Pharmaceutical and CSL Behring. Breaking the Cycle: Unlocking the Untapped Opportunities in Healthcare Innovation We've seen how transformative innovation can be when supported by focused investment. But if we want to continue advancing healthcare in meaningful ways, we must expand our lens and invest in the spaces that have been left behind. The Secret To Improved Population Health Management May Be In Our Pockets The rapid advances in AI and smartphone technologies hold promise for many stakeholders in the healthcare system — providers, payers, pharmaceutical drugmakers and public health agencies — that need to understand what's happening with the patient in real time.

Video   Women's Health Isn't Just About Reproductive Issues About 70% of investment in women's health goes towards wellness and reproductive issues — but that's not a holistic view of women's health, noted Amani Bright of Springboard Enterprises. She thinks more understanding of the full scope of women's health will lead to more investment. After all, women make up half of the population, so there is a huge investment opportunity when it comes to women's health outside of the scope of reproductive organs, Bright said.

Sponsored Expert Care in Houston: Top-Rated Hand and Wrist Surgeons You Can Trust Presented by Fondren Orthopedic Group Too many people sacrifice their quality of life by putting off a surgical procedure. Discover the top-rated hand and wrist surgeons in the Houston area who can help. Learn More.

Resources

MedCity FemFwd: Inside Springboard Enterprises and Accenture's New Women's Health Report In this episode, we're joined by Julia Lasater, management consulting senior analyst at Accenture, and Amani Bright, senior program manager at Springboard Enterprises. They discuss the key takeaways of their recent women's health report. Watch now!

MedCity News • PO Box 901 • New York, NY unsubscribe